Set Your Sights On Lexicon Pharmaceuticals Inc (NASDAQ: LXRX)’S Upside Potential
Lexicon Pharmaceuticals Inc (LXRX) concluded trading on Thursday at a closing price of $1.51, with 3.42 million shares of worth about $5.17 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -23.74% during that period and on September 25, 2024 the price saw a […]
Growing Through Challenges? – Lexicon Pharmaceuticals Inc (LXRX)
Currently, there are 244.93M common shares owned by the public and among those 238.68M shares have been available to trade. Insiders at the company have transacted a total of 56 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 47 of these insider trades were purchases, […]
Lexicon Pharmaceuticals Inc (NASDAQ: LXRX): The Best-Of-Breed For Investing?
Currently, there are 244.93M common shares owned by the public and among those 238.79M shares have been available to trade. Insiders at the company have transacted a total of 56 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 47 of these insider trades were purchases, […]
Lexicon Pharmaceuticals Inc (NASDAQ: LXRX): Analyst View Points To Future Growth
Lexicon Pharmaceuticals Inc (LXRX) concluded trading on Wednesday at a closing price of $2.15, with 4.03 million shares of worth about $8.66 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 18.13% during that period and on Wednesday February 7 the price saw a […]
Are Analysts Expecting A Better 2020 For Lexicon Pharmaceuticals Inc (LXRX)?
Lexicon Pharmaceuticals Inc (LXRX) concluded trading on Wednesday at a closing price of $1.87, with 4.94 million shares of worth about $9.23 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -3.61% during that period and on Wednesday, January 31 the price saw a […]
Look At Analyst Expectations For A Better Read On Lexicon Pharmaceuticals Inc (NASDAQ: LXRX)
BlackRock Fund Advisors recently announced the acquisition of new stake in Lexicon Pharmaceuticals Inc (NASDAQ:LXRX). The institutional investor has increased its shareholding in the Healthcare company by 4.54% to 5.98 million shares with purchase of 0.26 million shares. This fresh investment now brings its stake to 2.44% valued currently at $9.15 million. In addition, Millennium […]
There Is Clear Momentum For Lexicon Pharmaceuticals Inc (NASDAQ: LXRX)
Lexicon Pharmaceuticals Inc (LXRX) concluded trading on 01/04/24 at a closing price of $1.60, with 3.35 million shares of worth about $5.35 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -27.93% during that period and on Thursday the price saw a gain of […]
Lexicon Pharmaceuticals Inc (LXRX): Not A Time To Panic Nor Freeze
BlackRock Fund Advisors has recently announced that it has increased stake in Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) by 4.54%. After grabbing 5.98 million shares, the institutional investor is now in possession of 0.26 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 2.44% having worth around $6.34 million. Moreover, […]
